Liminal BioSciences

Liminal Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with fibrosis-related diseases. The company is advancing promising small molecule research for a range of fibrosis-related conditions, including respiratory, liver, and kidney diseases. Through an independent business unit named Prometic, the company also focuses on using bioseparation technologies to isolate and purify biopharmaceuticals derived from human plasma.